Retinoic acid inhibits osteogenic differentiation of mouse embryonic palate mesenchymal cells

Area of Science:

• Developmental Biology
• Cell Biology
• Molecular Biology

Background:

• All-trans-retinoic acid (ATRA) is a teratogen known to affect craniofacial development, including cleft palate.
• Mouse embryonic palate mesenchymal (MEPM) cells provide a model to study palatogenesis.
• Understanding ATRA's effects on MEPM cell differentiation is crucial for elucidating craniofacial developmental mechanisms.

Purpose of the Study:

• To investigate the impact of ATRA on the osteogenic and adipogenic differentiation of MEPM cells.
• To explore the molecular mechanisms underlying ATRA's influence on bone and fat cell development in the palate.

Main Methods:

• MEPM cells were isolated from gestational day 13 mouse embryos.
• Cells were induced to differentiate in osteogenic medium (OM) or control medium (CM) with or without ATRA.
• Osteogenic differentiation was assessed using alkaline phosphatase (ALP) activity, von Kossa staining, and RT-PCR for osteoblastic gene expression.

Main Results:

• MEPM cells successfully underwent osteogenic differentiation in OM, confirmed by ALP activity, mineralization, and gene expression.
• ATRA treatment increased ALP activity and lipid accumulation but did not induce matrix mineralization or osteoblastic gene expression.
• ATRA altered BMP signaling pathway components, decreasing BMPR-IB and Smad5 mRNA while increasing BMPR-IA mRNA levels.

Conclusions:

• ATRA, in conjunction with the BMP signaling pathway, inhibits osteogenesis in MEPM cells.
• ATRA promotes adipogenesis in MEPM cells.
• These findings suggest a mechanism by which ATRA may contribute to cleft palate development.